Seoul, South Korea

Woong Woo Park


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Woong Woo Park: Innovator in Radiopharmaceuticals

Introduction

Woong Woo Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for labeling technetium and rhenium compounds. With a total of 2 patents, his work is paving the way for advancements in medical applications.

Latest Patents

His latest patents include a "Method for labelling technetium or rhenium using borohydride exchange resin." This method allows for the direct labeling of disulfide compounds with technetium or rhenium, eliminating the need for synthetic steps involving thiol-protected S-precursors. This innovation is particularly useful for creating high value-added radiopharmaceuticals. Another notable patent is the "Method for the preparation of technetium or rhenium complex for radiopharmaceuticals." This invention describes a process that utilizes a borohydride exchange resin as a reducing agent, which is stable across a wide pH range and can be easily removed through filtration. The resulting radiolabeled complex boasts high radiochemical purity and labeling efficiency, making it a significant improvement over conventional methods.

Career Highlights

Woong Woo Park is affiliated with the Korea Atomic Energy Research Institute, where he continues to advance research in the field of radiopharmaceuticals. His work is characterized by a commitment to innovation and excellence, contributing to the development of safer and more effective medical treatments.

Collaborations

He has collaborated with notable colleagues, including Kyung Bae Park and Sang Hyun Park, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Woong Woo Park's contributions to the field of radiopharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work not only enhances the efficiency of radiolabeling processes but also holds promise for future applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…